... the biopharmaceutical company's stock worth $4,194,000 after buying an additional 57,727 shares in the last quarter. Ardsley Advisory Partners grew its position in shares of Amicus Therapeutics by 16.1% during the second quarter. Ardsley Advisory ...
https://sportsperspectives.com/2018/09/17/insider-buying-amicus-therapeutics-inc-fold-major-shareholder-purchases-6000000-00-in-stock.html
No comments:
Post a Comment